OSE Immunotherapeutics – executive interview

OSE Immunotherapeutics – executive interview

OSE Immunotherapeutics — 3 videos in collection

More on this equity

OSE Immunotherapeutics is an immunotherapy company based in Nantes and Paris, France, and is listed on the Euronext Paris exchange. It is developing immunotherapies for the treatment of solid tumours and autoimmune diseases and has established several partnerships with large pharma companies.

In this video, the company’s chief executive officer Alexis Peyroles provides an overview of R&D progress, including the recently announced COVID-19 prophylactic vaccine programme and expected newsflow.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free